Dermapharm Holding SE

Dermapharm Holding SE: Wilhelm Beier, buy

Dermapharm Holding SE: Anja Schorn, buy

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

Dermapharm Holding SE builds on success in Q3 2023

Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall

Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment

Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share

Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit

Dermapharm Holding SE: outstanding start to financial year 2023

Dermapharm Holding SE: Benjamin Dreibholz, buy

Dermapharm Holding SE: Katharina Dreibholz, buy

Dermapharm Holding SE: Christof Dreibholz, buy

Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory

Dermapharm Holding SE: 2022 dividend

Dermapharm Holding SE: Dermapharm Holding SE’s revenue exceeds one billion for the first time

Dermapharm Holding SE: Christof Dreibholz, buy

Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma

Dermapharm Holding SE successfully maintains growth trend as planned

EQS-DD: Dermapharm Holding SE english

EQS-DD: Dermapharm Holding SE english